QQ客服 官方微博 反馈留言

浏览/检索结果: 共72条，第1-10条 帮助 限定条件 发表日期：2018    专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Histone deacetylation, as opposed to promoter methylation, results in epigenetic BIM silencing and resistance to EGFR TKI in NSCLC 期刊论文 ONCOLOGY LETTERS, 2018, 卷号: 15, 期号: 1 作者:   收藏  |  浏览/下载：16/0  |  提交时间：2019/12/05 epidermal growth factor receptor-tyrosine kinase inhibitors  non-small cell lung cancer  bcl-2-like protein 11  histone deacylation  methylation   Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer 期刊论文 INVESTIGATIONAL NEW DRUGS, 2018, 卷号: 36, 期号: 2 作者:  Ouyang, Xuenong;  Shi, Meiqi;  Jie, Fangwei;  Bai, Yuxian;  Shen, Peng 收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05 Phase III  Dulanermin  NSCLC  Progression-free survival  Objective response rate   Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN) a randomised, open-label, phase 2 trial 期刊论文 LANCET RESPIRATORY MEDICINE, 2018, 卷号: 6, 期号: 11 作者:  Yue, Dongsheng;  Xu, Shidong;  Wang, Qun;  Li, Xiaofei;  Shen, Yi 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non- small cell lung cancer (EMERGING): A randomised study 会议论文 作者:  Zhong, W-Z.;  Wu, Y-L.;  Chen, K-N.;  Chen, C.;  Gu, C-D. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Ring finger protein 38 promote non-small cell lung cancer progression by endowing cell EMT phenotype 期刊论文 JOURNAL OF CANCER, 2018, 卷号: 9, 期号: 5 作者:  Xiong, Dian;  Zhu, Shu-Qiang;  Wu, Yong-Bing;  Jin, Chun;  Jiang, Jia-Hao 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 RNF38  NSCLC  EMT  Prognosis  Survival   Preliminary application of SPECT/CT imagingby(99)Tc(m)-tricine-EDDA-Hynic-c-Met for non-small-cell lung cancer 会议论文 作者:  Shi, Hongcheng;  Cheng, Dengfeng;  Zhang, Yiqiu 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Dexamethasone alleviates pemetrexed-induced senescence in Non-Small-Cell Lung Cancer 期刊论文 FOOD AND CHEMICAL TOXICOLOGY, 2018, 卷号: 119 作者:  Ge, Haiyan;  Ke, Jun;  Xu, Nuo;  Li, Hongqing;  Gong, Jin 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Senescence-associated secretory phenotype  Pemetrexed  Dexamethasone  Cancer stem cells  Non-small cell lung cancer   Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation. 期刊论文 Oncotarget, 2018, 卷号: 9, 期号: 35 作者:  Sun Chang;  Zhang Zhuojun;  Qie Jingbo;  Wang Yi;  Qian Ji 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 NSCLC  SLC31A1  SNP  microRNA  pharmacogenetics   Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer 期刊论文 CANCER MANAGEMENT AND RESEARCH, 2018, 卷号: 10 作者:  Xie, Liyi;  Lin, Chen;  Zhang, Qingfu;  Piao, Hailan;  Bigner, Darell D. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 podoplanin  squamous non-small cell lung cancer  pleural invasion  prognosis  molecular targeted therapy  immunotoxins   HSPA12B overexpression induces cisplatin resistance in non-small-cell lung cancer by regulating the PI3K/Akt/NF-kappa B signaling pathway 期刊论文 ONCOLOGY LETTERS, 2018, 卷号: 15, 期号: 3 作者:  Chen, Wei;  Liu, Xiaoqun;  Yuan, Sujuan;  Qiao, Tiankui 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 non-small cell lung cancer  heat shock protein family A member 12B  cisplatin  phosphoinositide 3-kinase/protein kinase B/nuclear factor-kappa B signaling pathway